Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Baxter International (NY: BAX)
61.38 USD  +0.70 (+1.15%)
Official Closing Price  /  Updated: 8:04 PM EDT, Jun 23, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,900,607
Open 60.68
Bid (Size) 61.29 (100)
Ask (Size) 61.44 (100)
Prev. Close 60.68
Today's Range 60.45 - 61.51
52wk Range 42.22 - 61.51
Shares Outstanding 541,957,424
Dividend Yield 0.90%
Performance
YTD
+38.12%
+38.12%
1 Month
+3.79%
+3.79%
3 Month
+18.43%
+18.43%
6 Month
+38.31%
+38.31%
1 Year
+39.98%
+39.98%
Top News
More News
Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline
Collaboration advances Baxter’s strategy of becoming a leader in generic injectables Read More
from Business Wire News Releases
Baxter Announces U.S. FDA Approval and Commercial Launch of Ready-to-Use Clindamycin Injection in Saline
Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of... Read More
from Business Wire News Releases
More News
Read More
Baxter Presents Data on Telehealth’s Role in Improving Peritoneal Dialysis Patient Care at ERA-EDTA 2017
from Business Wire News Releases
How Altimmune Is Trying To Get Ahead Of A Potential 'Flu Pandemic'
category Seasonal Flu , Exclusives , Pandemic Flu , and 24 more.
from Benzinga
New Data Demonstrates High Performance of HDx Enabled by THERANOVA, Baxter’s Novel Hemodialysis Therapy
from Business Wire News Releases
BRIEF-Baxter announces agreement with Dorizoe Lifesciences to further expand generic injectables pipeline
category companyNews
from Reuters: Company News
Baxter International Moves Up In Market Cap Rank, Passing HCA Healthcare
category Stocks
from Market News Video
Baxter to Present Significant Data at ERA-EDTA 2017 to Help Advance New Standards of Renal Care
from Business Wire News Releases
BRIEF-Baxter announces U.S. FDA approval, commercial launch of ready-to-use clindamycin injection in saline
category companyNews
from Reuters: Company News
Uptrend Call Working As Baxter International Stock Rises 30.0% (BAX)
from Comtex SmarTrend® News Briefs
Baxter and Mayo Clinic Launch Research and Development Collaboration to Transform Patient Care
from Business Wire News Releases
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial